IBL HealthCare Ltd. (IBLHL): FY24 Analyst Briefing takeaways – By AKD Research
Nov 26 2024
AKD Securities
- IBL HealthCare Ltd. (IBLHL) held its corporate briefing today to discuss its FY24 financial results and future outlook. Following are the key highlights:
- Company posted topline of PkR3.6bn in FY24 compared to PkR4.0bn in FY23, down 11% YoY, due to supply chain constraints amid plant shutdown of Mead Johnson in Thailand.
- Moreover, company’s profit for the year clocked in at PkR7.6mn (EPS: PkR0.09) in FY24 compared to PkR309mn (EPS: PkR3.61) in FY23, due to discounts offered amid limited shelf life of food products.
Current:
Open:
Volume:
Change: ()
High:
Low:
52 Week High:
Vol Avg(12 m):
Free Float:
52 Week Low:
Market Cap:
Total Share:
Relative Strength Index (RSI)
RSI:
MACD Signals
MACD DAILY:
MACD WEEKLY:
Simple Moving Avg (SMA)
SMA(10):
SMA(30):
SMA(60):
SMA(200):
Performance
One Month:
Three Months:
Six Months:
Twelve Months:
Support & Resistance
Support 1:
Resistance 1:
Support 2:
Resistance 2:
High & Lows
Period
High
Low